Terminal Sterilization Services Industry Overview
The global terminal sterilization services market size was valued at USD 9.80 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 10.63% from 2022 to 2030. Increasing growing number of surgical procedures, increasing incidence of hospital-acquired infections, rise in prevalence of chronic diseases, and rapid technological advancement are the major factors anticipated to drive the market growth globally.
There has been an increase in the number of surgical procedures performed globally. For instance, according to a research article published in NCBI in 2020, around 310 million surgeries are performed annually worldwide. Similarly, according to the American Society of Plastic Surgeons (ASPS), in 2018, over 17.7 million surgeries and minimally invasive cosmetic procedures took place in the U.S. Moreover, as per Molnlycke Health Care AB, around 70 million surgical procedures are performed in Europe, growing by 3% to 4% annually. Most of the surgeries involve at least one device that has been sterilized by using EtO. For instance, surgical kits, gowns, heart valves, pacemakers, drapes, syringes, catheters, and ventilators are among the medical devices that require EtO sterilization. Thus, the rising number of surgeries is expected to boost the market growth.
Gather more insights about the market drivers, restraints, and growth of the Global Terminal Sterilization Services Market
The increasing incidence of HAIs is expected to positively impact the market during the forecast period. For instance, according to National Institute for Health and Care Excellence (NICE), around 300,000 patients in England suffer from HAIs every year. Similarly, as per Patient Care Link, in American hospitals alone, an estimated population of 1.7 million people is infected with HAIs, which accounts for the approximately 99,000 associated deaths annually. Thus, with an increase in HAIs, the demand for terminal sterilization is anticipated to grow, thereby impelling the market during the forecast period.
Moreover, an increase in the prevalence of chronic diseases is expected to increase the demand for terminal sterilization. For instance, as per WHO, more than 40% of people aged 65+ in the UK have reported at least one chronic disease, whereas, 15% of people have at least two chronic diseases. Similarly, according to European Commission, cardiovascular disease is the biggest cause of death in the UK. Furthermore, the rate of stroke in U.K. is increasing. For instance, as per Stroke Association, a stroke strikes every 5 minutes in U.K., whereas there are 1.3 million stroke survivors in the UK. Thus, many people are opting for invasive surgery, which is indirectly contributing to the growth of the terminal sterilization services market.
Additionally, rapid technological advancements have led to the launch of various innovative products in the market, which is expected to impel the market growth.
Browse through Grand View Research's Medical Devices Industry Related Reports
Sterilization Equipment Market - The global sterilization equipment market size was valued at USD 7.2 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 10.5% from 2022 to 2030.
Infection Control Market - The global infection control market size was estimated at USD 201.4 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2022 to 2030.
Terminal Sterilization Services Market Segmentation
Grand View Research has segmented the global terminal sterilization services market report on the basis of product, end use, and region:
Terminal Sterilization Services Product Outlook (Revenue, USD Million, 2018 - 2030)
- Ethylene Oxide
- Irradiation
- X-ray
- Gamma (Co-60)
- E-beam
- Others
- Moist Heat Terminal Sterilization
- Others
Terminal Sterilization Services End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital & Clinics
- Pharma & Nutraceuticals
- Medical Device Manufacturing/Packaging
- Other Manufacturing Sectors (Semiconductor, Food/Confectionaries, Chemical/Materials)
- Academic Research Institutes
- Others
Terminal Sterilization Services Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Market Share Insights:
January 2021: STERIS plc signed an agreement to acquire Cantel Medical, a provider of infection prevention services & products, through its U.S. subsidiary in a transaction valued at approximately USD 4.6 billion in cash. Through this acquisition, the company was expected to offer a diversified range of infection prevention and procedural products & service.
Key Companies profiled:
Some prominent players in the global Terminal Sterilization Services market include
- Steris PLC
- 3M
- Getinge AB
- ASP (Fortive)
- Belimed, Inc. (Metal Zug Group)
- Sterigenics U.S., LLC- A Sotera Health Company
- Fedegari Group
- Olympus Corporation
- Andersen Sterilizers
- Steelco S.P.A
Order a free sample PDF of the Terminal Sterilization Services Market Intelligence Study, published by Grand View Research.
No comments:
Post a Comment